發(fā)布時間：2025-02-05 11:03

　　背景:急性缺氧性呼吸衰竭(acute hypoxemic respiratory failure,AHRF)是急診科和重癥監(jiān)護(hù)病房患者死亡的主要原因之一。當(dāng)前,無創(chuàng)通氣(non-invasive ventilation,NIV)對于急性缺氧性呼吸衰竭患者的療效仍存在爭議。但最近研究表明,高流量鼻導(dǎo)管(high-flow nasal cannula,HFNC)或可作為有效的治療方法來取代替代傳統(tǒng)氧療方法。問題:對新發(fā)急性缺氧性呼吸衰竭患者的而言,高流量鼻導(dǎo)管的療效如何?目的:本研究旨在闡述高流量鼻導(dǎo)管在新發(fā)急性缺氧性呼吸衰竭中的應(yīng)用價值。研究方法:本研究在“谷歌學(xué)術(shù)”和“PubMed”數(shù)據(jù)庫檢索相關(guān)文章,然后對文章進(jìn)行歸納整理。檢索關(guān)鍵詞為:“efficacy”、“high flow nasal cannula”、“high flow oxygen nasal therapy”、“de novo acute hypoxemic respiratory failure”和“acute hypoxemic respiratory failure”。結(jié)果:本文主要回顧了當(dāng)前關(guān)于高流量鼻導(dǎo)管治療急...

【文章頁數(shù)】：54 頁

【學(xué)位級別】：碩士

【文章目錄】：
中文摘要
ENGLISH ABSTRACT
ABBREVIATIONS
CHAPTER 1:INTRODUCTION
    1.1 BACKGROUND
    1.2 LITERATURE REVIEW
        1.2.1 Epidemiology of Respiratory Failure
        1.2.2 Respiratory Physiology
        1.2.3 Pathophysiology of Respiratory Failure
        1.2.4 De Novo Acute Hypoemic Respiratory Failure
        1.2.5 High Flow Nasal Cannula
CHAPTER 2:METHODOLOGY
    2.1 STUDY DESIGN
    2.2 DATA COLLECTION
        2.2.1 Inclusion criteria
        2.2.2 Exclusion criteria
    2.3 ETHICAL CONSIDERATION AND APPROVAL
CHAPTER 3:RESULTS
    3.1 CLINICAL BENEFITS OF HFNC THERAPY
CHAPTER 4: DISCUSSION
CHAPTER 5:CONCLUSION
    5.1 STUDY LIMITATION
    5.2 STUDY INNOVATION
CHAPTER 6:REFERENCES
ACKNOWLEDGMENT
PUBLISHED ARTICLE
學(xué)位論文評閱及答辯情況表



本文編號：4029734